Loading…
Reported covered position: Staff Director, Ways and Means Health Subcommittee; Professional Staff, Ways and Means Health Subcommittee; Health Policy Aide, Rep. Nancy Johnson; Legislative Assistant, Rep. Jim Ramstad
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed FY 27 rules for inpatient hospital prospective payment system.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC · Firm: FEDERAL HEALTH POLICY STRATEGIES
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ACTIVE PROTECTIVE via FEDERAL HEALTH POLICY STRATEGIES
2026 · third_quarter · Q3
Medicare payment and coverage issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIGHTSPRING HEALTH SERVICES via FEDERAL HEALTH POLICY STRATEGIES
2026 · third_quarter · Q3
Source: Senate LDA
| NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE |
| 16 |
| 2021–2024 |
| ALLIANCE OF COMMUNITY HEALTH PLANS | 7 | 2021–2022 |
| AMERISOURCEBERGEN CORPORATION | 7 | 2021–2022 |
| BRIGHTSPRING HEALTH SERVICES | 7 | 2025–2026 |
| PRUITTHEALTH CORPORATION | 5 | 2022 |
| ACCOMPANY HEALTH | 3 | 2025–2026 |
| NORTH AMERICAN PARTNERS IN ANESTHESIA | 3 | 2022–2023 |
| RXFUNCTION | 3 | 2024–2025 |
| VEKTOR MEDICAL | 3 | 2025 |
| ACTIVE PROTECTIVE | 2 | 2026 |
| FIND SOLACE, INC. | 2 | 2023 |
| ABBOTT LABORATORIES | 1 | 2021 |
| EMERUS HOLDINGS, INC. | 1 | 2021 |
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed CY hospital outpatient and post acute rules.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed FY 27 rules for inpatient hospital prospective payment system.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed CY hospital outpatient and post acute rules.
Preserving Patient Access to Home Infusion Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Home Infusion Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Home Infusion Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Medicare Advantage Improvement Act of 2026
Client: SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 8375/.4834 Medicare Advantage Improvement Act; issues related to Medicare Advantage enrollee access to inpatient rehabilitation facility care; issues related to affordability and quality of IRF care; issues related to FY 27 proposed rule for Inpatient Rehabilitation Facility Services
Medicare Advantage Improvement Act of 2026
Client: SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 8375/.4834 Medicare Advantage Improvement Act; issues related to Medicare Advantage enrollee access to inpatient rehabilitation facility care; issues related to affordability and quality of IRF care; issues related to FY 27 proposed rule for Inpatient Rehabilitation Facility Services; issues related to Review Choice Demonstration Program.
Preserving Patient Access to Home Infusion Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Home Infusion Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Home Infusion Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; related to mandatory program extender policies including delaying Medicaid DSH reductions; issues related to HRSA 340B program; H.R. 1, One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; H.R.1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; H.R.1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; related to mandatory program extender policies including delaying Medicaid DSH reductions; issues related to HRSA 340B program; H.R. 1, One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Home Health Stabilization Act of 2025
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
Home Health Stabilization Act of 2025
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
Home Health Stabilization Act of 2025
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
Home Health Stabilization Act of 2025
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Home Health Stabilization Act of 2025
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Home Health Stabilization Act of 2025
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Harmful Algal Bloom and Hypoxia Research and Control Amendments Act of 2025
Client: MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL · Firm: FEDERAL HEALTH POLICY STRATEGIES
Modernizing Opioid Treatment Access Act (S. 1359/H.R. 644) Access to medication-assisted treatment and Medicaid reform
STOP CCP Act of 2025
Client: MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL · Firm: FEDERAL HEALTH POLICY STRATEGIES
Modernizing Opioid Treatment Access Act (S. 1359/H.R. 644) Access to medication-assisted treatment and Medicaid reform
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Access to Prescription Digital Therapeutics Act of 2023
Client: PFIZER · Firm: FEDERAL HEALTH POLICY STRATEGIES
Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)S. 2115/H.R. 4307 the Medical Supply Chain Resiliency Act H.R. 8816, the American Medical Innovation and Investment Act
Access to Prescription Digital Therapeutics Act of 2023
Client: PFIZER · Firm: FEDERAL HEALTH POLICY STRATEGIES
Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458) H.R. 8816, the American Medical Innovation and Investment Act
Access to Prescription Digital Therapeutics Act of 2023
Client: PFIZER · Firm: FEDERAL HEALTH POLICY STRATEGIES
Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)S. 2115/H.R. 4307 the Medical Supply Chain Resiliency ActH.R. 8816, the American Medical Innovation and Investment Act
Access to Prescription Digital Therapeutics Act of 2023
Client: PFIZER · Firm: FEDERAL HEALTH POLICY STRATEGIES
Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)
Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)S. 2115/H.R. 4307 the Medical Supply Chain Resiliency Act H.R. 8816, the American Medical Innovation and Investment Act
Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)S. 2115/H.R. 4307 the Medical Supply Chain Resiliency ActH.R. 8816, the American Medical Innovation and Investment Act
Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024; H.R. 5074/S. 4510 Kidney PATIENT Act
Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024
Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 5027, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024
Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024; H.R. 5074/S. 4510 Kidney PATIENT Act
Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 5027, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024
Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024, issues related to CY 2025 CMS final rule for ESRD PPS and Quality Improvement Program.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024, issues related to CY 2025 CMS final rule for ESRD PPS and Quality Improvement Program.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024
Kidney PATIENT Act of 2023
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 5027, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024
Kidney PATIENT Act of 2023
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024
Kidney PATIENT Act of 2023
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024, issues related to CY 2025 CMS final rule for ESRD PPS and Quality Improvement Program.
Kidney PATIENT Act of 2023
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 5027, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024
Kidney PATIENT Act of 2023
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024, issues related to CY 2025 CMS final rule for ESRD PPS and Quality Improvement Program.
Kidney PATIENT Act of 2023
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024; H.R. 5074/S. 4510 Kidney PATIENT Act
Kidney PATIENT Act of 2023
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024
Kidney PATIENT Act of 2023
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024; H.R. 5074/S. 4510 Kidney PATIENT Act
Preserving Access to Home Health Act of 2023
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025, Government Funding legislation, continuing resolutions.
Preserving Access to Home Health Act of 2023
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025.
Preserving Access to Home Health Act of 2023
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025, Government Funding legislation, continuing resolutions.
Preserving Access to Home Health Act of 2023
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025, Government Funding legislation, continuing resolutions.
Preserving Access to Home Health Act of 2023
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025.
Preserving Access to Home Health Act of 2023
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025.
Preserving Access to Home Health Act of 2023
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025.
Preserving Access to Home Health Act of 2023
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025, Government Funding legislation, continuing resolutions.
Preserving Access to Home Health Act of 2023
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act
Preserving Access to Home Health Act of 2023
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to cancer treatment and radiation oncology.
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program.
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to cancer treatment and radiation oncology.
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program.
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program, government funding and continuing resolutions.
Issues related to FY 2025 CMS Proposed IPPS rule; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program, government funding and continuing resolutions.
Issues related to Fy 2025 CMS Proposed IPPS rule; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Student Loan Borrower Safety Net Act of 2023
Client: MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL · Firm: FEDERAL HEALTH POLICY STRATEGIES
Modernizing Opioid Treatment Access Act (S. 1359/H.R. 644)
Student Loan Borrower Safety Net Act of 2023
Client: MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL · Firm: FEDERAL HEALTH POLICY STRATEGIES
Modernizing Opioid Treatment Access Act (S. 1359/H.R. 644)
Student Loan Borrower Safety Net Act of 2023
Client: MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL · Firm: FEDERAL HEALTH POLICY STRATEGIES
Modernizing Opioid Treatment Access Act (S. 1359/H.R. 644)
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH via FEDERAL HEALTH POLICY STRATEGIES
2026 · third_quarter · Q3
H.R. 8375/.4834 Medicare Advantage Improvement Act; issues related to Medicare Advantage enrollee access to inpatient rehabilitation facility care; issues related to affordability and quality of IRF care; issues related to FY 27 proposed rule for Inpatient Rehabilitation Facility Services; issues related to Review Choice Demonstration Program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER via FEDERAL HEALTH POLICY STRATEGIES
2026 · third_quarter · Q3
Drug pricing and prescription digital therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL via FEDERAL HEALTH POLICY STRATEGIES
2026 · third_quarter · Q3
Access to medication-assisted treatment and Medicaid reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2026 · third_quarter · Q3
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed CY hospital outpatient and post acute rules.
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed CY hospital outpatient and post acute rules.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via FEDERAL HEALTH POLICY STRATEGIES
2026 · third_quarter · Q3
Issues impacting coverage of end-stage renal disease.
Issues impacting coverage of end-stage renal disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2026 · third_quarter · Q3
Issues impacting the Medicare Advantage Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACTIVE PROTECTIVE via FEDERAL HEALTH POLICY STRATEGIES
2026 · third_quarter · RR
Medicare recognition of medical device
BRIGHTSPRING HEALTH SERVICES via FEDERAL HEALTH POLICY STRATEGIES
2026 · second_quarter · Q2
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH via FEDERAL HEALTH POLICY STRATEGIES
2026 · second_quarter · Q2
H.R. 8375/.4834 Medicare Advantage Improvement Act; issues related to Medicare Advantage enrollee access to inpatient rehabilitation facility care; issues related to affordability and quality of IRF care; issues related to FY 27 proposed rule for Inpatient Rehabilitation Facility Services
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER via FEDERAL HEALTH POLICY STRATEGIES
2026 · second_quarter · Q2
Drug pricing and prescription digital therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL via FEDERAL HEALTH POLICY STRATEGIES
2026 · second_quarter · Q2
Access to medication-assisted treatment and Medicaid reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2026 · second_quarter · Q2
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed FY 27 rules for inpatient hospital prospective payment system.
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed FY 27 rules for inpatient hospital prospective payment system.
FRESENIUS MEDICAL CARE NORTH AMERICA via FEDERAL HEALTH POLICY STRATEGIES
2026 · second_quarter · Q2
Issues impacting coverage of end-stage renal disease.
Issues impacting coverage of end-stage renal disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2026 · second_quarter · Q2
Issues impacting the Medicare Advantage Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACCOMPANY HEALTH via FEDERAL HEALTH POLICY STRATEGIES
2026 · first_quarter · Q1
Issues impacting the Medicare Advantage program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIGHTSPRING HEALTH SERVICES via FEDERAL HEALTH POLICY STRATEGIES
2026 · first_quarter · Q1
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH via FEDERAL HEALTH POLICY STRATEGIES
2026 · first_quarter · Q1
Medicare payment policies and access to inpatient rehabilitation facility (IRF) care generally; Medicare Review Choice Demonstration program; issues related to Medicare Advantage enrollee access to inpatient rehabilitation facility care; issues related to affordability and quality of IRF care.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER via FEDERAL HEALTH POLICY STRATEGIES
2026 · first_quarter · Q1
Drug pricing and prescription digital therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL via FEDERAL HEALTH POLICY STRATEGIES
2026 · first_quarter · Q1
Access to medication-assisted treatment and Medicaid reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2026 · first_quarter · Q1
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally.
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via FEDERAL HEALTH POLICY STRATEGIES
2026 · first_quarter · Q1
Issues impacting coverage of end-stage renal disease.
Issues impacting coverage of end-stage renal disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2026 · first_quarter · Q1
Issues impacting the Medicare Advantage Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACCOMPANY HEALTH via FEDERAL HEALTH POLICY STRATEGIES
2025 · fourth_quarter · Q4
Issues impacting the Medicare Advantage program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIGHTSPRING HEALTH SERVICES via FEDERAL HEALTH POLICY STRATEGIES
2025 · fourth_quarter · Q4
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH via FEDERAL HEALTH POLICY STRATEGIES
2025 · fourth_quarter · Q4
Medicare payment policies and access to inpatient rehabilitation facility care generally; Medicare Review Choice Demonstration program; issues related to Medicare Advantage enrollee access to inpatient rehabilitation facility care.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER via FEDERAL HEALTH POLICY STRATEGIES
2025 · fourth_quarter · Q4
Drug pricing and prescription digital therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL via FEDERAL HEALTH POLICY STRATEGIES
2025 · fourth_quarter · Q4
Access to medication-assisted treatment and Medicaid reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2025 · fourth_quarter · Q4
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally.
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via FEDERAL HEALTH POLICY STRATEGIES
2025 · fourth_quarter · Q4
Issues impacting coverage of end-stage renal disease.
Issues impacting coverage of end-stage renal disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2025 · fourth_quarter · Q4
Issues impacting the Medicare Advantage Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACCOMPANY HEALTH via FEDERAL HEALTH POLICY STRATEGIES
2025 · fourth_quarter · RR
Issues impacting Medicare Advantage
VEKTOR MEDICAL via FEDERAL HEALTH POLICY STRATEGIES
2025 · third_quarter · Q3
Medicare coverage and reimbursement of software as a service
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRIGHTSPRING HEALTH SERVICES via FEDERAL HEALTH POLICY STRATEGIES
2025 · third_quarter · Q3
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH via FEDERAL HEALTH POLICY STRATEGIES
2025 · third_quarter · Q3
Medicare payment policies and access to inpatient rehabilitation facility care generally; Medicare Review Choice Demonstration program; issues related to Medicare Advantage enrollee access to inpatient rehabilitation facility care.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER via FEDERAL HEALTH POLICY STRATEGIES
2025 · third_quarter · Q3
Implementation of the drug pricing provisions in the Inflation Reduction Act Drug pricing and prescription digital therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL via FEDERAL HEALTH POLICY STRATEGIES
2025 · third_quarter · Q3
Access to medication-assisted treatment and Medicaid reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2025 · third_quarter · Q3
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; H.R.1, One Big Beautiful Bill Act
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; H.R.1, One Big Beautiful Bill Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via FEDERAL HEALTH POLICY STRATEGIES
2025 · third_quarter · Q3
Issues impacting coverage of end-stage renal disease.
Issues impacting coverage of end-stage renal disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2025 · third_quarter · Q3
Issues impacting the Medicare Advantage Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VEKTOR MEDICAL via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · Q2
Medicare coverage and reimbursement of software as a service.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIGHTSPRING HEALTH SERVICES via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · Q2
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act
SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · Q2
Medicare payment policies and access to inpatient rehabilitation facility care generally; Medicare Review Choice Demonstration program; issues related to Medicare Advantage enrollee access to inpatient rehabilitation facility care.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · Q2
Implementation of the drug pricing provisions in the Inflation Reduction Act Drug pricing and prescription digital therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · Q2
Access to medication-assisted treatment and Medicaid reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · Q2
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; related to mandatory program extender policies including delaying Medicaid DSH reductions; issues related to HRSA 340B program; H.R. 1, One Big Beautiful Bill Act.
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; related to mandatory program extender policies including delaying Medicaid DSH reductions; issues related to HRSA 340B program; H.R. 1, One Big Beautiful Bill Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · Q2
Issues impacting coverage of end-stage renal disease.
Issues impacting coverage of end-stage renal disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · Q2
Issues impacting the Medicare Advantage Program
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VEKTOR MEDICAL via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · RR
Medicare reimbursement issues
BRIGHTSPRING HEALTH SERVICES via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · RR
Issues related to long term care pharmacy and adjacent community-based services for seniors and disabled populations; Medicare home health agency prospective payment system
Issues related to long term care pharmacy and adjacent community-based services for seniors and disabled populations; Medicare home health agency prospective payment system
Issues related to long term care pharmacy and adjacent community-based services for seniors and disabled populations; Medicare home health agency prospective payment system
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2025 · first_quarter · Q1
Issues related to Medicaid program financing; issues related to continuous coveage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; related to mandatory program extender policies including delaying Medicaid DSH reductions; isssues related to HRSA 340B program; government funding and continuing resolutions.
Issues related to Medicaid program financing; issues related to continuous coveage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; related to mandatory program extender policies including delaying Medicaid DSH reductions; isssues related to HRSA 340B program; government funding and continuing resolutions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH via FEDERAL HEALTH POLICY STRATEGIES
2025 · first_quarter · Q1
Medicare payment policies and access to inpatient rehabilitation facility care generally; Medicare Advantage Policy and Technical Change Proposed Rule for 2026; Medicare Advantage network adequacy standards for inpatient rehabilitation facility services; Medicare Review Choice Demonstration program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCAN HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2025 · first_quarter · Q1
Issues impacting the Medicare Advantage Program
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RXFUNCTION via FEDERAL HEALTH POLICY STRATEGIES
2025 · first_quarter · Q1
Medicare reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via FEDERAL HEALTH POLICY STRATEGIES
2025 · first_quarter · Q1
Implementation of the drug pricing provisions in the Inflation Reduction Act Drug pricing and prescription digital therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL via FEDERAL HEALTH POLICY STRATEGIES
2025 · first_quarter · Q1
Modernizing Opioid Treatment Access Act (S. 1359/H.R. 644) Access to medication-assisted treatment and Medicaid reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via FEDERAL HEALTH POLICY STRATEGIES
2025 · first_quarter · Q1
Issues impacting coverage of end-stage renal disease.
Issues impacting coverage of end-stage renal disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via FEDERAL HEALTH POLICY STRATEGIES
2024 · fourth_quarter · 4T
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025, Government Funding legislation, continuing resolutions.
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025, Government Funding legislation, continuing resolutions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2024 · fourth_quarter · Q4
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program, government funding and continuing resolutions.
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program, government funding and continuing resolutions.
SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH via FEDERAL HEALTH POLICY STRATEGIES
2024 · fourth_quarter · Q4
Medicare payment policies and access to inpatient rehabilitation facility care generally; Medicare Advantage Policy and Technical Change Proposed Rule for 2025; Medicare Advantage network adequacy standards for inpatient rehabilitation facility services; Medicare Review Choice Demonstration program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCAN HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2024 · fourth_quarter · Q4
Issues impacting the Medicare Advantage Program
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RXFUNCTION via FEDERAL HEALTH POLICY STRATEGIES
2024 · fourth_quarter · Q4
Medicare reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via FEDERAL HEALTH POLICY STRATEGIES
2024 · fourth_quarter · Q4
Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458) H.R. 8816, the American Medical Innovation and Investment Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via FEDERAL HEALTH POLICY STRATEGIES
2024 · fourth_quarter · Q4
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025, Government Funding legislation, continuing resolutions.
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025, Government Funding legislation, continuing resolutions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL via FEDERAL HEALTH POLICY STRATEGIES
2024 · fourth_quarter · Q4
Modernizing Opioid Treatment Access Act (S. 1359/H.R. 644)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via FEDERAL HEALTH POLICY STRATEGIES
2024 · fourth_quarter · Q4
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024, issues related to CY 2025 CMS final rule for ESRD PPS and Quality Improvement Program.
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024, issues related to CY 2025 CMS final rule for ESRD PPS and Quality Improvement Program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RXFUNCTION via FEDERAL HEALTH POLICY STRATEGIES
2024 · fourth_quarter · RR
Medicare reimbursement
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2024 · third_quarter · Q3
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program.
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH via FEDERAL HEALTH POLICY STRATEGIES
2024 · third_quarter · Q3
FY 2025 Propsoed Rule for Inpatient Rehabiiliation Facilities; Medicare payment policies and access to inpatient rehabilitation facility care generally, CMS 4207-NC Request for Information on Medicare Advantage data; Medicare Advantage network adequacy standards for inpatient rehabilitation facility services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCAN HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2024 · third_quarter · Q3
Issues impacting the Medicare Advantage Program
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER via FEDERAL HEALTH POLICY STRATEGIES
2024 · third_quarter · Q3
Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)S. 2115/H.R. 4307 the Medical Supply Chain Resiliency Act H.R. 8816, the American Medical Innovation and Investment Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via FEDERAL HEALTH POLICY STRATEGIES
2024 · third_quarter · Q3
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025.
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL via FEDERAL HEALTH POLICY STRATEGIES
2024 · third_quarter · Q3
Modernizing Opioid Treatment Access Act (S. 1359/H.R. 644)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via FEDERAL HEALTH POLICY STRATEGIES
2024 · third_quarter · Q3
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2024 · second_quarter · Q2
Issues related to FY 2025 CMS Proposed IPPS rule; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Issues related to Fy 2025 CMS Proposed IPPS rule; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH via FEDERAL HEALTH POLICY STRATEGIES
2024 · second_quarter · Q2
FY 2025 Proposed Rule for Inpatient Rehabiliation Facilities; Medicare payment policies and access to inpatient rehabilitation facility care generally, CMS 4207-NC Request for Information on Medicare Advantage data.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCAN HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2024 · second_quarter · Q2
Issues impacting the Medicare Advantage Program
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER via FEDERAL HEALTH POLICY STRATEGIES
2024 · second_quarter · Q2
Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)S. 2115/H.R. 4307 the Medical Supply Chain Resiliency ActH.R. 8816, the American Medical Innovation and Investment Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via FEDERAL HEALTH POLICY STRATEGIES
2024 · second_quarter · Q2
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025.
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL via FEDERAL HEALTH POLICY STRATEGIES
2024 · second_quarter · Q2
Modernizing Opioid Treatment Access Act (S. 1359/H.R. 644)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via FEDERAL HEALTH POLICY STRATEGIES
2024 · second_quarter · Q2
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024; H.R. 5074/S. 4510 Kidney PATIENT Act
H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024; H.R. 5074/S. 4510 Kidney PATIENT Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2024 · first_quarter · Q1
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to cancer treatment and radiation oncology.
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to cancer treatment and radiation oncology.
SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH via FEDERAL HEALTH POLICY STRATEGIES
2024 · first_quarter · Q1
Review Choice Demonstration for Inpatient Rehabilitation Facilities (CMS-10765), Medicare payment policies and access to inpatient rehabilitation facility care generally, CMS 4207-NC Request for Information on Medicare Advantage data.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCAN HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2024 · first_quarter · Q1
Issues impacting the Medicare Advantage Program
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER via FEDERAL HEALTH POLICY STRATEGIES
2024 · first_quarter · Q1
Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via FEDERAL HEALTH POLICY STRATEGIES
2024 · first_quarter · Q1
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL via FEDERAL HEALTH POLICY STRATEGIES
2024 · first_quarter · Q1
Modernizing Opioid Treatment Access Act (S. 1359/H.R. 644)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via FEDERAL HEALTH POLICY STRATEGIES
2024 · first_quarter · Q1
H.R. 5027, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024
H.R. 5027, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2023 · fourth_quarter · Q4
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH via FEDERAL HEALTH POLICY STRATEGIES
2023 · fourth_quarter · Q4
Review Choice Demonstration for Inpatient Rehabilitation Facilities (CMS-10765), Medicare payment policies and access to inpatient rehabilitation facility care generally
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCAN HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2023 · fourth_quarter · Q4
Issues impacting the Medicare Advantage Program
Filing targets: Health & Human Services, Dept of (HHS)
PFIZER via FEDERAL HEALTH POLICY STRATEGIES
2023 · fourth_quarter · Q4
Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via FEDERAL HEALTH POLICY STRATEGIES
2023 · fourth_quarter · Q4
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL via FEDERAL HEALTH POLICY STRATEGIES
2023 · fourth_quarter · Q4
Modernizing Opioid Treatment Access Act (S. 1359/H.R. 644)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via FEDERAL HEALTH POLICY STRATEGIES
2023 · fourth_quarter · Q4
H.R. 5027, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024
H.R. 5027, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FIND SOLACE, INC. via FEDERAL HEALTH POLICY STRATEGIES
2023 · fourth_quarter · Q4
Funding opportunities related to increasing health equity, improving access
Filing targets: Health & Human Services, Dept of (HHS)
FIND SOLACE, INC. via FEDERAL HEALTH POLICY STRATEGIES
2023 · fourth_quarter · RR
Issues affecting health equity and care quality in Medicare and Medicaid
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2023 · third_quarter · Q3
Issues related to CMS proposed rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedy rules; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Issues related to CMS proposed rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedy rules; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH via FEDERAL HEALTH POLICY STRATEGIES
2023 · third_quarter · Q3
Review Choice Demonstration for Inpatient Rehabilitation Facilities (CMS-10765)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE